INZY – inozyme pharma, inc. (US:NASDAQ)
Stock Stats
News
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock.
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
Form 10-Q Inozyme Pharma, Inc. For: Mar 31
Form 8-K Inozyme Pharma, Inc. For: May 07
Form ARS Inozyme Pharma, Inc. For: Dec 31
Form DEFA14A Inozyme Pharma, Inc.
Form DEF 14A Inozyme Pharma, Inc. For: Jun 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.